Independent evidence before payment.
Do not buy this to take yourself.
This seller lists prescription-medicine ingredients, and we could not match it to any regulated route allowed to supply them.
If you need this medicine, get it from a pharmacy on the GPhC register.
Search the GPhC pharmacy registerResearch catalogue uses 4 prescription-medicine ingredient names; this is not a verified human-use route
We could not find a public registration record for its domain (so its age is unknown); a matching active UK company is on the Companies House register (NEW-U LTD, 13353849); 7 of 8 transparency signals were found on its own published pages. With no independent lab results or verified community reviews yet, Litmus publishes these public-record facts but does not yet assign an overall trust score.
Decision first
Prescription-only, warned or investigational listings detected: Semaglutide, Tirzepatide, Tesamorelin, PT-141, Retatrutide, Cagrilintide. A research-only disclaimer does not make these approved consumer products.
NEW-U LTD (13353849). Company existence does not verify products or human-use legality.
A COA or exact batch report may describe research material; it cannot create an approved medicine or lawful prescription route.
Hard-to-fake records we checked at the source — registers, the ICANN domain record, independent lab verification, regulator actions.
No public domain-registration (RDAP) record was found, so the website's age is unknown.
How we checked · We never infer a domain's age. With no RDAP record the signal is left unknown — an absence, not a penalty.
Matches NEW-U LTD (company 13353849) on the UK Companies House register — active, incorporated 23 Apr 2021.
How we checked · An exact, active match on a public company register is a hard-to-fake positive. We only claim a match when a single active company exactly matches the brand.
The dated seller-catalogue snapshot uses 4 active-ingredient names also found in approved prescription medicines (Semaglutide, Tirzepatide, Tesamorelin, PT-141); the research listing does not inherit the branded medicine's approval and is presented under a “research use only” disclaimer. Lists 2 investigational drugs with no approved formulation (Retatrutide, Cagrilintide).
How we checked · A hard fail requires direct human-use or no-prescription conduct on the seller's site, or an official adverse event, plus a dated product-status receipt. An ingredient name never inherits a branded medicine's approval.
Potential medicines-law risk. Our dated catalogue check recorded 4 prescription-only medicines (Semaglutide, Tirzepatide, Tesamorelin, PT-141) in a direct research-sales catalogue, while no regulated prescriber and dispensing-pharmacy route was matched. UK rules generally restrict the supply of prescription-only medicines. This is a factual risk flag, not a legal determination about the seller. The site uses a “research use only” label. That label does not itself establish that a sale complies with medicines law.
How we checked · We flag the observed catalogue facts against official medicines guidance. This is a prompt to check the regulator sources, not a legal judgment about the seller.
No independent lab results on file yet.
How we checked · Only independent HPLC/MS results count toward a lab score. A vendor's own certificates of analysis are shown but never unlock a score — they're too easy to cherry-pick.
No regulator actions against this vendor are on record in the sources we monitor.
How we checked · We surface published actions from the FDA, MHRA and other regulators. Absence reflects the sources we monitor, not a clean bill of health.
Circumstantial signals that are hard to fake at scale — operator fingerprints, what the seller publishes, payment routes.
6 of 8 transparency signals were published on the vendor's own site (crawled 30 Jul 2026).
How we checked · Counts only signals the vendor actually publishes — named lab, batch COAs, shipping origin, working support, and so on. “Not found” earns no credit but is never scored as a failure.
Checked against the vendor's own published pages. “Unknown” means the fetched pages did not provide usable evidence; it is never a failed check.
No verified community reviews yet.
How we checked · We need at least 3 credible, non-manipulation reviews before any experience score is shown. Trustpilot-style star scores are excluded by design — they're the easiest signal to fake.
No shared-operator fingerprint was detected among the signals we checked.
How we checked · We look for shared naming, templates and infrastructure across brands. A clean result reflects the signals we checked, not a guarantee of independence.
Accepts: Card, PayPal, Bank transfer, Cryptocurrency, Peer-to-peer transfer.
How we checked · Stable card processing means a payment processor did some KYC — a weak positive. Crypto-only / transfer-only payment is a caution because there is no chargeback recourse. Read from the seller's own published pages.
Shown for completeness only. A seller controls these completely, so they earn zero trust weight — a claim is not a verification.
Publishes its own certificate-of-analysis documents.
How we checked · A vendor-published COA is the vendor's own claim — cherry-pickable and copyable — so it earns no trust weight. It would move to Tier 1 only if the report number verified against the lab's own records.
Labels products “research use only” on its own site.
How we checked · A self-applied RUO label is the vendor's own wording. It earns no trust weight, and it does not change what the law requires for a prescription-only medicine.
States it ships from United Kingdom.
How we checked · Ship origin is self-reported by the seller and is not independently verified — displayed as their claim only.
We do not collect or display Trustpilot-style star scores for this or any seller.
How we checked · Star-review walls can be bought, brigaded or review-gated, and a real one can't be told from a manipulated one at source — so they earn zero trust weight here by design.
Links go to the compound's evidence page — we sell nothing and never link to a checkout.